Skip to main content

Corona Virus Infection

5
Pipeline Programs
9
Companies
9
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
3
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

9 companies ranked by most advanced pipeline stage

Bharat Biotech
Bharat BiotechIndia - Hyderabad
1 program
1
COVAXINPhase 21 trial
Active Trials
NCT05639998Completed608Est. Jul 2022
SaNOtize
SaNOtizeBC - Vancouver
1 program
1
NORSPhase 21 trial
Active Trials
NCT04337918Completed143Est. Feb 2021
Sironax
SironaxChina - Beijing
1 program
1
SIR1-365Phase 11 trial
Active Trials
NCT04622332Completed45Est. Nov 2021
Medpace
MedpaceCINCINNATI, OH
1 program
1
ZotatifinPhase 11 trial
Active Trials
NCT04632381Completed36Est. Sep 2023
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
1
anti-SARS-CoV-2 human convalescent plasmaPhase 11 trial
Active Trials
NCT04462848Unknown30Est. Dec 2024
Hamilton medical
Hamilton medicalSwitzerland - Bonaduz
1 program
Awake ProningN/A1 trial
Active Trials
NCT04350723Completed400Est. Jul 2021
iNova Pharmaceuticals
iNova PharmaceuticalsAustralia - Chatswood
1 program
COVID-19 positive via testingN/A1 trial
Active Trials
NCT04398264Completed650Est. Mar 2021
Allergy Therapeutics
Allergy TherapeuticsUK - West Sussex
1 program
Flu shotN/A1 trial
Active Trials
NCT04579588Recruiting230Est. Apr 2028
Beyond Air
Beyond AirIsrael - Rehovot
1 program
Nitric Oxide delivered via LungFit™ systemN/A1 trial
Active Trials
NCT04397692Terminated4Est. Sep 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Bharat BiotechCOVAXIN
SaNOtizeNORS
MedpaceZotatifin
SironaxSIR1-365
Angeles Therapeuticsanti-SARS-CoV-2 human convalescent plasma
Allergy TherapeuticsFlu shot
iNova PharmaceuticalsCOVID-19 positive via testing
Beyond AirNitric Oxide delivered via LungFit™ system
Hamilton medicalAwake Proning

Clinical Trials (9)

Total enrollment: 2,146 patients across 9 trials

NCT05639998Bharat BiotechCOVAXIN

BBV152/BBV154 Heterologus Prime-Boost Study

Start: Sep 2021Est. completion: Jul 2022608 patients
Phase 2Completed
NCT04337918SaNOtizeNORS

Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection

Start: May 2020Est. completion: Feb 2021143 patients
Phase 2Completed
NCT04632381MedpaceZotatifin

Intravenous Zotatifin in Adults With Mild or Moderate COVID-19

Start: Jul 2021Est. completion: Sep 202336 patients
Phase 1Completed
NCT04622332SironaxSIR1-365

A Pilot Study to Assess Safety and Efficacy of SIR1-365 in Patients With Severe COVID-19

Start: Dec 2020Est. completion: Nov 202145 patients
Phase 1Completed
NCT04462848Angeles Therapeuticsanti-SARS-CoV-2 human convalescent plasma

Covid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical Conditions

Start: Aug 2020Est. completion: Dec 202430 patients
Phase 1Unknown
NCT04579588Allergy TherapeuticsFlu shot

Understanding Immunity to the Flu Vaccine in COVID-19 Patients

Start: Oct 2020Est. completion: Apr 2028230 patients
N/ARecruiting
NCT04398264iNova PharmaceuticalsCOVID-19 positive via testing

Characteristics of COVID-19 Infection Among PREGnant Women

Start: Jul 2020Est. completion: Mar 2021650 patients
N/ACompleted
NCT04397692Beyond AirNitric Oxide delivered via LungFit™ system

Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial)

Start: Jun 2020Est. completion: Sep 20204 patients
N/ATerminated
NCT04350723Hamilton medicalAwake Proning

Awake Prone Position in Hypoxemic Patients With Coronavirus Disease 19 COVID-19 (COVI-PRONE)

Start: Jun 2020Est. completion: Jul 2021400 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 2,146 patients
9 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.